ESC 365 - CA125 outperforms NT-proBNP in the prediction of maximum aerobic capacity in heart failure with preserved ejection fraction and cardiorenal syndrome

HFA Premium Access

CA125 outperforms NT-proBNP in the prediction of maximum aerobic capacity in heart failure with preserved ejection fraction and cardiorenal syndrome

Session: ePosters in chronic heart failure - pharmacotherapy 6

Topic: Rehabilitation

Speaker: Mr G. Nunez Marin (Valencia, ES)

Event: Heart Failure 2024

Congress Presentation

About the speaker

Mr Gonzalo Nunez Marin

Instituto de Investigacion Sanitaria INCLIVA, Valencia (Spain)

0 follower

4 more presentations in this session

What factors are associated with myocardial recovery following admission for acute heart failure? Study in patients with de novo diagnosis and reduced left ventricular ejection fraction

Speaker: Mr V. Donoso (Valencia, ES)

Nation-wide use of guideline-directed medical therapies in heart failure across the ejection fraction range: The HECMOS study

Speaker: Doctor I. Leontsinis (Athens, GR)

SGLT2i treatment at the beginning of real time exposure in a HFrEF population

Speaker: Associate Professor V. Vintila (Bucharest, RO)

The daily challenges to patients posed by diuretic therapy; what they are and what do patients do?

Speaker: Doctor G. Bruno (Dublin, IE)

Access the full session

ePosters in chronic heart failure - pharmacotherapy 6

Speakers: Mr G. Nunez Marin, Mr V. Donoso, Doctor I. Leontsinis, Associate Professor V. Vintila, Doctor G. Bruno

About the event

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources